Dr. Friedlander is the President of LMRI, Professor at TSRI, and Chief of Retina Services at the Scripps Clinic. He oversees a laboratory program that is focused on understanding basic mechanisms that regulate the growth of new blood vessels as well as cell-cell interactions that help maintain normal neuronal function in the retina. His laboratory is interested in “translational” research with the goal of identifying new therapies to treat retinal diseases, including Macular Telangiectasia type 2.
